Navigation Links
IDRI and Medicago report positive results for Phase I clinical trial for an H5N1 vaccine
Date:4/17/2013

order to collect and compare data.

The trial focused on evaluating the safety and immunogenicity of the H5N1 vaccine, combined with IDRI's GLA adjuvant, which has been exclusively licensed to Immune Design Corp for certain fields, including influenza. The vaccine was administered intramuscularly or intradermally. The intradermal route of administration was also tested in comparison with intramuscular delivery, using an FDA licensed device (MicronJet600, NanoPass Technologies) as the micro-needle device was previously shown in seasonal and pandemic flu tests to allow significant dose sparing. This study is among the first to test intradermal adjuvants and is the first time GLA has been tested intradermally.

Safety and Immunogenicity Results

The H5N1 vaccine candidate has been tested in over 300 healthy volunteers to date, none of which have experienced any serious adverse reactions. The H5N1 vaccine candidate was found to be safe and well tolerated. As planned in the clinical design, monitoring of adverse events will continue for one year.

All three configurations of adjuvant and route of administration for 20ug of the H5N1 vaccine candidate induced a solid immune response against the H5N1 viral strain that exceeded the CHMP immunogenicity criteria for licensure of influenza vaccines which are 40% seroconversion, 70% seroprotection and 2.5x geometric mean increase (GMI). For a 20ug dose of the H5N1 vaccine plus; 2.5ug GLA-AF administered intradermally (ID), 2.5ug GLA-AF delivered Intramuscularly (IM) and 0.5ug alum formulation administered IM, a four-fold increase in HI titers (seroconversion) was observed in 65.0%, 80.0% and 83.3% of subjects, respectively. The seroprotection rate was 70.0%, 85.0% and 89.9%, respectively. The GMI was 10.3x, 8.7x, and 11.4x, respectively.

About H5N1

According to the Centers for Disease Control and Prevention, the highly pathogenic avian influenza A (H5N1) virus is a
'/>"/>

Contact: Lee Schoentrup
lee.schoentrup@idri.org
206-858-6064
Infectious Disease Research Institute
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. IDRI and Medicago to present data at the World Vaccine Congress
2. IDRI and Medicago announce authorization to initiate a Phase 1 clinical trial for an H5N1 vaccine
3. U.S. Infant Mortality Rates Finally Dropping Again: Report
4. Molecule treats leukemia by preventing cancer cell repair, Jackson Laboratory scientists report
5. Rally in Support of Child Victims Act Kicked off Yesterday in New York, Reports Alonso Krangle
6. New study finds digoxin safe despite recent reports
7. Magnet hospitals achieve lower mortality, reports Medical Care
8. St Jude Retreats Releases New Infographic Which Reports Consequences of Drunk Driving
9. First NuvaRing Lawsuits in State, Federal NuvaRing Litigations Set to Head to Trial Later This Year, Alonso Krangle LLP Reports
10. Lucintel Report Outlines $100 Billion Market for Global Oncology Drugs Industry in 2018
11. Rescheduling of First NuvaRing Lawsuit Trials in State, Federal NuvaRing Lawsuit Litigation, Reports Wright & Schulte LLC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2015)... (PRWEB) May 03, 2015 Women’s ... their Facebook page. , Their Facebook page ... many services the Practice has, it’s multiple locations, Providers ... Women’s Excellence has a very strong social media presence, ... and You Tube. , Women’s Excellence is the ...
(Date:5/3/2015)... Francisco, CA (PRWEB) May 03, 2015 ... (CFHI), announced it will be awarding the 2015 ... Jennifer Knight and Selemawit Ghebrendrias, are the deserving recipients ... champion for global service, Harris Llewellyn Wofford. The two ... service and passion for global health. , CFHI ...
(Date:5/3/2015)... (PRWEB) May 03, 2015 Indiana Fiber ... Provider announces Bank Computer Services, Inc (BCS) has selected ... BCS’ President states, “The technology, service, and working relationship ... like is the local feel you get with IFN. ... managed company; IFN makes local decisions and operates as ...
(Date:5/3/2015)... 03, 2015 Looking for a ... directly impact your career? The Master of International ... leaders in multinational companies and for professionals seeking ... changing global landscape, differences in culture, religion, government, ... EMIB program develops the global competence and confidence ...
(Date:5/3/2015)... MA (PRWEB) May 03, 2015 SpineFrontier, ... clearance from the FDA to produce and market their ... device can be used in outpatient settings and is ... The alternate posterior approach has been extensively researched and ... 510k approval to use this approach in conjunction with ...
Breaking Medicine News(10 mins):Health News:SF-based Global Health Non-Profit Awards Harris Wofford Global Service Fellowship 2Health News:SF-based Global Health Non-Profit Awards Harris Wofford Global Service Fellowship 3Health News:Bank Computer Services, Inc Selects Indiana Fiber Network, LLC as Fiber Transport Provider 2Health News:Bank Computer Services, Inc Selects Indiana Fiber Network, LLC as Fiber Transport Provider 3Health News:The Saint Louis University's Master of International Business Is Now Enrolling For Fall 2015 2
... CHICAGO, Oct. 11 Continuing its efforts ... SAVE THE PATIENT, a,not-for-profit patient-focused organization, is hosting ... Network. "Community Health Hotline" will,air Monday, October 15, ... Monday,s program will feature a frank discussion on ...
... simple tool that can improve the effectiveness of communication ... in dramatic improvements in health and safety. , The ... color images of the medication to be taken each ... a patient,s native language if the patient does not ...
... LOUIS, Oct. 11 KV Pharmaceutical Company,(NYSE: KVa/KVb) ... the Special Committee of the Board of Directors ... On October 11, 2007, KV,s Board of ... submitted findings on the internal,investigation of the Company,s ...
... Society volunteers break, national campaign record for free ... Texas, Oct. 11 High temperatures and intense,sunshine ... Hot Air,Balloon Festival to the Women,s Dermatologic Society ... number of free skin,cancer screenings for this 13th ...
... tests are good front-line tests indicators of heart disease, but ... say. , Thirty percent of all women, for example, ... walk for several minutes at a slightly increasing incline with ... say. , So if you are female, I put you ...
... Oct. 11 Amylin Pharmaceuticals,Inc. (Nasdaq: AMLN ) ... quarter of 2007 on Wednesday, October 17, 2007 at ... and Chief Executive,Officer, will lead the call. On the ... the third quarter of 2007. The call will ...
Cached Medicine News:Health News:Patient Empowerment -- Medication Error 2Health News:Improving doctor-patient communication yields significant health benefits 2Health News:Improving doctor-patient communication yields significant health benefits 3Health News:Improving doctor-patient communication yields significant health benefits 4Health News:KV Pharmaceutical Company Reports Results of Special Independent Committee Review of Stock Option Grants 2Health News:KV Pharmaceutical Company Reports Results of Special Independent Committee Review of Stock Option Grants 3Health News:KV Pharmaceutical Company Reports Results of Special Independent Committee Review of Stock Option Grants 4Health News:KV Pharmaceutical Company Reports Results of Special Independent Committee Review of Stock Option Grants 5Health News:KV Pharmaceutical Company Reports Results of Special Independent Committee Review of Stock Option Grants 6Health News:Sun Safety Awareness Reaches New Heights at Plano Hot Air Balloon Festival 2Health News:Sun Safety Awareness Reaches New Heights at Plano Hot Air Balloon Festival 3Health News:Taking the stress out of choosing the right stress test 2Health News:Taking the stress out of choosing the right stress test 3Health News:Amylin Pharmaceuticals to Webcast Third Quarter Results 2
(Date:5/1/2015)... , May 1, 2015  AcelRx Pharmaceuticals, Inc. (Nasdaq: ... the development and commercialization of innovative therapies for the ... Timothy E. Morris , chief financial officer  will ... the events are as follows: Mizuho Third ... Location:  The Omni Berkshire Place, New York ...
(Date:4/30/2015)... , April 30, 2015 /PRNewswire/ - Pivotal ... pharmaceutical company with a focus on Omega-3 therapies ... its operational highlights and financial results for the ... amounts referenced herein are in Canadian dollars unless ... have been significant, with the right strategic partners ...
(Date:4/30/2015)... SUNNYVALE, Calif. , April 30, 2015 /PRNewswire/ ... that it has signed an agreement with MIM ... for the TomoTherapy ® and CyberKnife ® ... both Accuray and MIM technology. This is Accuray,s ... to the development of the first iPad-based treatment ...
Breaking Medicine Technology:AcelRx Pharmaceuticals to Participate at Upcoming Investor Conferences in May 2Pivotal Therapeutics Announces 2014 Financial Results 2Pivotal Therapeutics Announces 2014 Financial Results 3Pivotal Therapeutics Announces 2014 Financial Results 4Pivotal Therapeutics Announces 2014 Financial Results 5Pivotal Therapeutics Announces 2014 Financial Results 6Accuray Signs Agreement with MIM Software Inc. to Develop Adaptive Therapy Software 2Accuray Signs Agreement with MIM Software Inc. to Develop Adaptive Therapy Software 3
... BRIDGEWATER, N.J. and TORONTO, Feb. 15, 2011 ... ) and Sunnybrook Health Sciences Centre (Toronto, Canada) announced ... licensing option for vasculotide, an investigational compound to treat ... by a lack of sensation and neuropathic ulcers that ...
... 15, 2011 Now, with your own personal Breast Angel ... going to be able to actually see inside your breasts. ... what your normal internal physiological appearance is, and more importantly, ... to be a dreaded procedure nor a confusing one. Interpreting ...
Cached Medicine Technology:Sanofi-aventis and Sunnybrook Health Sciences Centre Agree to Develop Treatment for Diabetic Foot Ulcers 2Sanofi-aventis and Sunnybrook Health Sciences Centre Agree to Develop Treatment for Diabetic Foot Ulcers 3Sanofi-aventis and Sunnybrook Health Sciences Centre Agree to Develop Treatment for Diabetic Foot Ulcers 4Breast Enlightenment Presents Breast Angel, the First Home Care Breast Health System, to Prevent Breast Cancer 2
... Optima L-XP ultracentrifuge is designed ... the discovery process if research involves ... a sophisticated on-board computer, enhanced firmware, ... easy-to-use touch screen, Optima L-XP delivers ...
... The Dimension Xpand integrated chemistry ... compact footprint to the smaller laboratory. ... The Dimension Xpand integrated chemistry system ... tailored for the low-volume environment, in ...
The Express Plus clinical chemistry analyzer is a fully automated walk away system designed for maximum productivity, convenience and reliability....
... make the RD/Hitachi 902 the clinical ... laboratory. Compact, sample selective clinical chemistry ... tests on board (including 3 ISE) ... per hour respectively up to 300 ...
Medicine Products: